Shedding Light on Novel Pathogenic and Therapeutic Aspects Related to Immune-Mediated Skin Diseases

por Chiricozzi, Andrea, Girolomoni, Giampiero
Publicado 2023

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis

por Blauvelt, Andrew, Chiricozzi, Andrea
Publicado 2018

IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants

por Saggini, Andrea, Chimenti, Sergio, Chiricozzi, Andrea
Publicado 2014

Brodalumab in the Treatment of Plaque Psoriasis Localized in Difficult-to-Treat Areas: A Narrative Review

por Cannizzaro, Maria Vittoria, Coscarella, Giulia, Chiricozzi, Andrea
Publicado 2023

Editorial: The immunobiology of the skin in response to the environment

por Donetti, Elena, Sommariva, Michele, Chiricozzi, Andrea, Prignano, Francesca
Publicado 2023

Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy

por D’Erme, Angelo Massimiliano, Romanelli, Marco, Chiricozzi, Andrea
Publicado 2017

Targeting IL-4 for the Treatment of Atopic Dermatitis

por Chiricozzi, Andrea, Maurelli, Martina, Peris, Ketty, Girolomoni, Giampiero
Publicado 2020

The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments

por Gisondi, Paolo, Bellinato, Francesco, Chiricozzi, Andrea, Girolomoni, Giampiero
Publicado 2020

Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies

por Chiricozzi, Andrea, Gisondi, Paolo, Bellinato, Francesco, Girolomoni, Giampiero
Publicado 2020

Successful treatment with secukinumab in an HIV‐positive psoriatic patient after failure of apremilast

por Romita, Paolo, Foti, Caterina, Calianno, Gianluca, Chiricozzi, Andrea
Publicado 2022

Lasers and Energy Devices for the Skin: Conventional and Unconventional Use

por Nistico, Steven Paul, Chiricozzi, Andrea, Tamburi, Federica, Cannarozzo, Giovanni
Publicado 2016

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential

por Chiricozzi, Andrea, De Simone, Clara, Fossati, Barbara, Peris, Ketty
Publicado 2019

Overview of Atopic Dermatitis in Different Ethnic Groups

por Chiricozzi, Andrea, Maurelli, Martina, Calabrese, Laura, Peris, Ketty, Girolomoni, Giampiero
Publicado 2023

Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review

por Blauvelt, Andrew, Chiricozzi, Andrea, Ehst, Benjamin D., Lebwohl, Mark G.
Publicado 2023

Scanning the Immunopathogenesis of Psoriasis

por Chiricozzi, Andrea, Romanelli, Paolo, Volpe, Elisabetta, Borsellino, Giovanna, Romanelli, Marco
Publicado 2018

Acne fulminans associated with lymecycline intake: a case report

por Gualtieri, Bruno, Tonini, Annalisa, Panduri, Salvatore, Chiricozzi, Andrea, Romanelli, Marco
Publicado 2018

Could Targeted Pharmacotherapies Exert a “Disease Modification Effect” in Patients with Chronic Plaque Psoriasis?

por Bellinato, Francesco, Chiricozzi, Andrea, Piaserico, Stefano, Targher, Giovanni, Gisondi, Paolo
Publicado 2022

Eruptive lentiginosis in resolving plaque psoriasis during treatment with risankizumab

por Palmisano, Gerardo, Di Stefani, Alessandro, Cappilli, Simone, Chiricozzi, Andrea, Peris, Ketty
Publicado 2023

Novel Therapeutic Strategies in the Topical Treatment of Atopic Dermatitis

por Pinto, Lorenzo Maria, Chiricozzi, Andrea, Calabrese, Laura, Mannino, Maria, Peris, Ketty
Publicado 2022

Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases

por Saraceno, Rosita, Talamonti, Marina, Galluzzo, Marco, Chiricozzi, Andrea, Costanzo, Antonio, Chimenti, Sergio
Publicado 2013